Demographic characteristics of hospitalized IBD patients

Sonnenberg, Amnon
November 2009
Digestive Diseases & Sciences;Nov2009, Vol. 54 Issue 11, p2449
Academic Journal
journal article
Background and Aims: The Nationwide Inpatient Sample of the Healthcare Cost and Utilization Project (HCUP) was used to study the recent demographic characteristics of patients with Crohn's disease (CD) or ulcerative colitis (UC).Methods: HCUP data of the period 1997-2006 were extracted. The data were stratified by the categories pertaining to patient demographics, such as age-group, sex, race, insurance type, income group, residence in metropolitan area and region of the United States, as well as categories pertaining to hospital characteristics, such as type of ownership, teaching status, location, and bed-size. The distributions of inpatients among different categories were compared between CD or UC and all other diagnoses, using odds ratios and their 95% confidence intervals for comparison.Results: The data revealed a slight female predominance in CD (1.08, 1.09-1.09) and a slight male predominance in UC (1.15, 1.14-1.15). Compared to patients with other diagnoses, patients with inflammatory bowel disease tended to be white (CD: 2.47, 2.45-2.50; UC: 2.13, 2.10-2.15), more affluent (CD: 1.44, 1.43-1.45; UC: 1.59, 1.58-1.61), live in metropolitan areas (CD: 1.09, 1.08-1.10; UC: 1.26, 1.25-1.27) and in the Northeast of the United States (CD: 1.27, 1.27-1.28; UC: 1.44, 1.43-1.45).Conclusions: These patterns confirm previously described characteristics of patients with inflammatory bowel disease and show that such characteristics still apply to present patient populations.


Related Articles

  • Nutritional status assessment of patients with inflammatory bowel disease. Prescha, Anna; Pieczy�ska, Joanna; Biernat, Katarzyna; Neubauer, Katarzyna; Smereka, Adam; Ilow, Rafat; Grajeta, Haliina; Biernat, Jadwiga; Paradowski, Leszek // Gastroenterologia Polska / Gastroenterology;2010, Vol. 17 Issue 1, p25 

    Introduction: Malnutrition often occurs in patients with inflammatory bowel disease (IBD), especially in the acute phase but also in remission, mostly as a result of improper diet. The aim of the study was to assess the nutritional status of patients with Crohn's disease (CD) and ulcerative...

  • The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease. Di Sabatino, A.; Battista, N.; Biancheri, P.; Rapino, C.; Rovedatti, L.; Astarita, G.; Vanoli, A.; Dainese, E.; Guerci, M.; Piomelli, D.; Pender, S. L. F.; MacDonald, T. T.; Maccarrone, M.; Corazza, G. R. // Mucosal Immunology (1933-0219);Sep2011, Vol. 4 Issue 5, p574 

    Activation of cannabinoid receptors (CBs) by endocannabinoids impacts on a number of gastrointestinal functions. Recent data indicate that CB1 agonists improve 2,4-dinitrobenzene sulfonic acid-induced colitis in mice, thus suggesting a role for the endocannabinoid agonist anandamide (AEA) in...

  • Lymphatic pump function in the inflamed gut.  // Inflammatory Bowel Disease Monitor;2011, Vol. 11 Issue 3, p125 

    The article presents a review on the pathological features of the lymphatic system that are seen in the inflammatory bowel disease (IBD) patients. It notes that ulcerative colitis (UC) and Crohn's diseases are chronic inflammatory disorders of the gastrointestinal (GI) tract. It discusses the...

  • Pulmonary involvement in inflammatory bowel disease.  // Inflammatory Bowel Disease Monitor;2011, Vol. 11 Issue 3, p128 

    The article presents a prospective study on the frequency of pulmonary involvement in inflammatory bowel disease (IBD) patients. It shows that 26% of patients had respiratory symptoms while 64% of patients had an abnormal high-resolution computed tomography (HRCT) scan. It adds that the two main...

  • Thyroid Disorders in Patients with Inflammatory Bowel Diseases. Yakut, Mustafa; Üstün, Yusuf; Kabacan, Gökhan; Soykan, Irfan // International Journal of Clinical Medicine;May2011, Vol. 2 Issue 2, p89 

    Background: The rate of thyroid disorders is reported to be increased in patients with Ulcerative Colitis (UC) and Crohn's disease (CD) than the normal population. The purpose of this study is to evaluate the prevalance of Thyroid disorders in a group of patients with inflammatory bowel diseases...

  • Worries and Concerns among Inflammatory Bowel Disease Patients Followed Prospectively over One Year. Jelsness-Jørgensen, Lars-Petter; Moum, Bjørn; Bernklev, Tomm // Gastroenterology Research & Practice;2011, Vol. 2011, p1 

    Disease-related worries are frequently reported in inflammatory bowel disease (IBD), but longitudinal assessments of these worries are scarce. In the present study, patients completed the rating form of IBD patient concerns (RFIPC) at three occasions during one year. One-way analysis of variance...

  • Mucosal Gene Expression of Cell Adhesion Molecules, Chemokines, and Chemokine Receptors in Patients With Inflammatory Bowel Disease Before and After Infliximab Treatment. Arijs, Ingrid; De Hertogh, Gert; Machiels, Kathleen; Van Steen, Kristel; Lemaire, Katleen; Schraenen, Anica; Van Lommel, Leentje; Quintens, Roel; Van Assche, Gert; Vermeire, Séverine; Schuit, Frans; Rutgeerts, Paul // American Journal of Gastroenterology;Apr2011, Vol. 106 Issue 4, p748 

    OBJECTIVES:Inflammatory bowel disease (IBD) is characterized by a continuous influx of leukocytes into the gut wall. This migration is regulated by cell adhesion molecules (CAMs), and selective antimigration therapies have been developed. This study investigated the effect of infliximab therapy...

  • Involvement of autotaxin/lysophospholipase D expression in intestinal vessels in aggravation of intestinal damage through lymphocyte migration. Hozumi, Hideaki; Hokari, Ryota; Kurihara, Chie; Narimatsu, Kazuyuki; Sato, Hirokazu; Sato, Shingo; Ueda, Toshihide; Higashiyama, Masaaki; Okada, Yoshikiyo; Watanabe, Chikako; Komoto, Shunsuke; Tomita, Kengo; Kawaguchi, Atsushi; Nagao, Shigeaki; Miura, Soichiro // Laboratory Investigation (00236837);May2013, Vol. 93 Issue 5, p508 

    Lysophosphatidic acid (LPA) has a critical role in lymphocyte migration to secondary lymphoid organs. Autotaxin (ATX)/lysophospholipase D, in the vascular endothelium, is the main enzyme involved in LPA production. Whether ATX is involved in pathological lymphocyte migration to the inflamed...

  • Non-Jewish Israeli IBD patients have significantly higher glutathione S-transferase GSTT1-null frequency. Karban, Amir; Krivoy, Norberto; Elkin, Hela; Adler, Lior; Chowers, Yehuda; Eliakim, Rami; Efrati, Edna // Digestive Diseases & Sciences;Jul2011, Vol. 56 Issue 7, p2081 

    Background: The involvement of oxidant/antioxidant imbalance in the development of inflammatory bowel disease (IBD) is well documented. Two members of the glutathione S-transferase (GST) family of enzymes, GSTM1 and GSTT1, known to take part in cellular protection against...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics